Immunostimulants drugs living meta-analysis of clinical studies

demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only

	COVID 19 hospitalized
	COVID 19 all comers
Immunostimulants drugs
convalescent plasma treatment	LIFESAVER

4861	Cai -FAVIPIRAVIR, 2020	1	31	0		not a RCT	risk of bias not avaialble
5183	Qiong Zhou, 2020	0	19	0	selection pending
5406	Duan, 2020	1	13	4		not a RCT	high risk of bias
5446	Sean, 2020	1	13	4		not a RCT	high risk of bias
5450	Pereda, 0	0	10	0	selection pending
5534	Wang (early IFN), 2020	0	13	4	selection pending
5549	Hegerova, 2020	1	13	4		not a RCT	high risk of bias
5550	Abolghasemi, 2020	1	13	4		not a RCT	high risk of bias
5565	Pereda, 2020	0	13	0	selection pending
5569	Dai W, 2020	2	13	4	excluded	not a RCT	high risk of bias
5572	Hao, 2020	0	20	0	selection pending
5662	Salazar, 2020	1	13	4		not a RCT	high risk of bias
5761	Joyner, 2020	1	31	3		not a RCT	high risk of bias
6140	Wang, 2020	0	13	0	selection pending
6159	Gemici, 2020	0	13	0	selection pending
6708	Webb, 2021	0	13	0	selection pending
6940	Bihariesingh-Sanchit (SuriCovid), 2021	1	31	0		not a RCT	risk of bias not avaialble